Table 2.

Association of FSAP Marburg I with venous thromboembolism



Venous thromboembolism


Total
Idiopathic
Secondary
Controls
No.   213   103   110   213  
FSAP Marburg I, no. (%)   17 (8.0%)   12 (11.7%)   5 (4.5%)   5 (2.3%)  
Odds ratio (95% CI)   3.5 (1.2-10.0)*  6.2 (2.0-18.9)  1.8 (0.49-7.0)   
Factor V Leiden, no. (%)   59 (27.7%)   25 (24.3%)   34 (30.9%)   16 (7.5%)  
Odds ratio (95% CI)   4.8 (2.7-8.8)  4.4 (2.2-8.8)  5.6 (2.9-10.7)  
PT 20210G→A, no. (%)   16 (7.5%)   6 (5.8%)   10 (9.1%)   7 (3.3%)  
Odds ratio (95% CI)
 
2.6 (1.0-6.6)*
 
2.5 (0.8-7.9)
 
3.1 (1.1-8.6)*
 

 


Venous thromboembolism


Total
Idiopathic
Secondary
Controls
No.   213   103   110   213  
FSAP Marburg I, no. (%)   17 (8.0%)   12 (11.7%)   5 (4.5%)   5 (2.3%)  
Odds ratio (95% CI)   3.5 (1.2-10.0)*  6.2 (2.0-18.9)  1.8 (0.49-7.0)   
Factor V Leiden, no. (%)   59 (27.7%)   25 (24.3%)   34 (30.9%)   16 (7.5%)  
Odds ratio (95% CI)   4.8 (2.7-8.8)  4.4 (2.2-8.8)  5.6 (2.9-10.7)  
PT 20210G→A, no. (%)   16 (7.5%)   6 (5.8%)   10 (9.1%)   7 (3.3%)  
Odds ratio (95% CI)
 
2.6 (1.0-6.6)*
 
2.5 (0.8-7.9)
 
3.1 (1.1-8.6)*
 

 

PT indicates prothrombin; CI, confidence interval.

*

P < .05, †P ≤ .001. Logistic regression model for history of VTE.

Close Modal

or Create an Account

Close Modal
Close Modal